Dow Up 0.11% Nasdaq Up 0.50%

Alkermes plc (ALKS)

-NasdaqGS
44.73 Up 0.25(0.56%) 3:59PM EDT
|After Hours : 44.74 Up 0.01 (0.01%) 4:44PM EDT
Prev Close:44.48
Open:44.74
Bid:39.04 x 100
Ask:51.48 x 100
1y Target Est:50.92
Beta:1.57
Next Earnings Date:N/A
Day's Range:44.37 - 45.07
52wk Range:29.36 - 54.25
Volume:374,852
Avg Vol (3m):728,166
Market Cap:6.52B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 0.56%6.52B
ABTDown 0.26%63.52B
LLYUp 0.71%68.12B
GSKUp 0.47%117.94B

Key Statistics

Forward P/E (1 yr):74.55
P/S (ttm):11.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):12.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback